Boardroom Alpha
Boardroom Alpha
NVEC · Additional Proxy Materials (DEFA14A) · Filed June 22, 2026

Nve Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
June 22, 2026
Ticker
NVEC
Accession
0000724910-26-000002
Boardroom Alpha · Filing insights

NVE Corporation's board urges voting FOR seven director nominees, advisory NEO compensation, and auditor ratification.

About Nve Corp
Market cap
$517M
1Y TSR
+95.3%
3Y TSR
+19.6%
Board grade
C+
Sector
Technology
CEO
Peter G. Eames
Last annual meeting: Aug 6, 2026 · View full Nve Corp profile →
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_______________

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.   )
Filed by the Registrant  ☑
Filed by a party other than the Registrant  ☐
 
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under § 240.14a-12
 
NVE Logo
NVE Corporation

(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check all boxes that apply):
No fee required.
   
Fee paid previously with preliminary materials.
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
   
   
   
   


 

Small NVE logo
11409 Valley View Road
Eden Prairie, MN 55344-3617
www.nve.com

 
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

Fellow Shareholders:

The Annual Meeting of Shareholders of NVE Corporation will be held Thursday, August 6, 2026, at 3:30 p.m. Central Daylight Time at our offices, 11409 Valley View Road, Eden Prairie, Minnesota, 55344. The Annual Meeting is being held for the following purposes:

           1.    Elect seven directors.
 
2. Advisory approval of named executive officer compensation.
 
3. Ratify the selection of Boulay PLLP as our independent registered public accounting firm for the fiscal year ending March 31, 2027.
 
4. Consider and act on such other business as may properly come before the meeting or any adjournment or postponements of the meeting.

These items of business are more fully described in the proxy statement. The Board of Directors recommends a vote FOR each of the Director nominees and FOR Proposals 2 and 3. Only shareholders of record at the close of business on the record date of June 12, 2026, are entitled to execute proxies or to vote at the 2026 Annual Meeting.

Our Proxy Materials include our 2026 Proxy Statement, our 2026 Letter to Shareholders, and our Annual Report on Form 10-K for the year ended March 31, 2026.

This Notice is being sent with paper copies of our Proxy Materials to shareholders of record, that is those whose shares were registered directly in shareholders’ names with our transfer agent as of the record date. Beneficial owners holding shares through a bank or broker are being sent a Notice of Internet Availability of Proxy Materials. Beneficial owners who want paper copies of our Proxy Materials must request them through their bank or broker.
 
Sincerely,
-s- Daniel A. Baker
Daniel A. Baker
President and CEO

June 22, 2026
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Nve Corp (NVEC)

Reference

Frequently asked questions

When did Nve Corp file this DEFA14A?
Nve Corp (NVEC) filed this Additional Proxy Materials (DEFA14A) with the SEC on June 22, 2026. The accession number assigned by EDGAR is 0000724910-26-000002.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
NVE Corporation's board urges voting FOR seven director nominees, advisory NEO compensation, and auditor ratification. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Nve Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Nve Corp has filed under CIK 724910, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer